Investment Summary

TPG Invests In Trevi Therapeutics

On December 18, 2012, private equity firm TPG invested in life science company Trevi Therapeutics

Investment Highlights
  • This is TPG’s 28th transaction in the Life Science sector.
  • This is TPG’s 134th transaction in the United States.
  • This is TPG’s 3rd transaction in Connecticut.
Investment Fate
  • Trevi Therapeutics went public in 2019.

Investment Summary

Date 2012-12-18
Target Trevi Therapeutics
Sector Life Science
Investor(s) TPG
Deal Type Venture

Target

Trevi Therapeutics

New Haven, Connecticut, United States
Trevi Therapeutics is a clinical-stage biotechnology company focused on the development and commercialization of Haduvio to treat serious neurologically mediated conditions. Trevi Therapeutics was formed in 2011 and is based in New Haven, Connecticut.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

TPG

Fort Worth, Texas, United States

Investor Investor Investor Investor


Category Private Equity Firm
Founded 1992
PE ASSETS 296.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

TPG Capital is a global, mega-sized private investment firm that manages a family of funds focused on private equity, real estate, venture capital, public equity and debt investing. TPG invests in opportunities across a broad range of industries and geographies. TPG generally seeks to invest in established businesses that can benefit from the Firm's operational experience and connections. Industries of interest include consumer, retail, healthcare, industrials, digital media, natural resources, energy, real estate, technology, and software. TPG was formerly known as Texas Pacific Group and was originally established in 1992 by David Bonderman, James Coulter and William Price. The Firm is based in Forth Worth, Texas with additional offices in Europe, Asia, and Australia.


DEAL STATS #
Overall 198 of 451
Sector: Life Science M&A 28 of 46
Type: Venture M&A Deals 48 of 93
State: Connecticut M&A 3 of 5
Country: United States M&A 134 of 298
Year: 2012 M&A 10 of 10
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2012-12-01 Gardman

Peterborough, United Kingdom

Gardman Ltd. is a provider of wild bird-care products such as seeds and feeders; tooling, gardening footwear and gloves; lighting; greenhouses; and pots, planters and hanging baskets. Gardman Ltd. was founded in 1992 and is based in Peterborough, United Kingdom.

Buy £85M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2013-01-01 Lilliput Kidswear

New Delhi, India

Lilliput Kidswear is a retailer of kids' apparel and accessories with a pan-nation distribution network, capacity to manufacture 11 million units per annum, and a strong and highly visible brand — 'Lilliput'. Lilliput is a cost leader because of its strong in-house manufacturing capability, which enables it to sell its merchandise to a price-sensitive target customer base at a discount to the international brands and other organized retailers and still earn attractive margins.

Sell -